Equity Plans and Stock-based Compensation (Tables)

3 Months Ended

Apr. 30, 2021

Share-based Payment Arrangement [Abstract]

Schedule of Equity Plans Activity

Activity under the Company’s equity plans is set forth below:

	Number of Stock Option Awards			Weighted Average Exercise Price		Weighted Average Remaining Contractual term (in years)		Aggregate Intrinsic Value (in thousands)
Outstanding as of January 31, 2021		30,166,792		$	0.71		7.3	$	1,064,539
Forfeited		(353,478	)	$	0.74
Expired		(17,350	)	$	58.74
Outstanding as of April 30, 2021		29,795,964		$	0.67		6.9	$	734,460
Options vested and expected to vest as of April 30, 2021		29,795,964		$	0.67		6.9	$	734,460
Exercisable as of April 30, 2021		18,248,059		$	0.64		6.0	$	450,546

Schedule of Stock Based compensation Expense

The following sets forth the total stock-based compensation expense for the Company’s stock options (including CEO awards) and restricted common stock included in the Company’s condensed consolidated statements of operations:

	Three Months Ended April 30,
	2021		2020
	(in thousands)
Cost of revenue	$	24	$	23
Research and development		675		302
Sales and marketing		598		299
General and administrative		6,280		286
Total stock-based compensation expense	$	7,577	$	910